Skip to content
A1773Assembly2023-2024 SessionSame asS9583

Require Naloxone at Key Sites

Official title

“Requires certain eligible persons or entities to acquire and possess opioid antagonists”

Sponsor Linda RosenthalAD-67+6 co-sponsorsAffects Health
Status
In Assembly Committee
Health
Impact
8/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires specified organizations and personnel in New York to acquire, possess, and maintain opioid antagonists like naloxone for emergency overdose treatment.

Why it matters

  1. Expands required access to opioid overdose reversal drugs. to a wide range of organizations and locations beyond medical settings—including schools, camps, community centers, government offices, shelters, correctional facilities, and even private contractors performing services at these sites—potentially increasing the likelihood of rapid intervention during an overdose.

  2. Mandates training and oversight for non-medical personnel. , ensuring that only designated individuals who have completed approved training (or who are acting under a healthcare provider’s direction) are allowed to administer opioid antagonists, which could improve safety and effective use in emergencies.

  3. Provides legal protections for those administering opioid antagonists. , clarifying that their use is considered first aid and does not count as unauthorized medical practice, which may reduce hesitation to intervene during an overdose and protect bystanders or employees from liability.

  4. Requires ongoing readiness and logistical management. , as organizations must always have at least two doses available and must follow state regulations on storage, maintenance, and disposal, possibly increasing administrative responsibilities but also ensuring preparedness for overdose incidents.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Require Naloxone at Key Sites

Plain English, a few words. Used as the page title.

Sponsors

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

S9583Senate

Require Naloxone in Public Places

In Senate Committee · Health · Sponsor Luis R. Sepúlveda

Impact 8 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

1773

2023-2024 Regular Sessions

IN ASSEMBLY

January 20, 2023

Introduced by M. of A. L. ROSENTHAL -- read once and referred to the Committee on Health

AN ACT to amend the public health law, in relation to requiring certain eligible persons or entities to acquire and possess opioid antagonists

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 3000-f to read as follows:

§ 3000-f. Opioid antagonist. 1. Definitions. As used in this section:

(a) "Eligible person or entity" means (i) an ambulance service or advanced life support first response service; a certified first responder, emergency medical technician, or advanced emergency medical technician, who is employed by or an enrolled member of any such service; (ii) a children's overnight camp as defined in subdivision one of section thirteen hundred ninety-two of this chapter, a summer day camp as defined in subdivision two of section thirteen hundred ninety-two of this chapter, a traveling summer day camp as defined in subdivision three of section thirteen hundred ninety-two of this chapter; or a person employed by such a camp; (iii) a school district, board of cooperative educational services, county vocational education and extension board, charter school, non-public elementary and secondary school, colleges, and universities in this state; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; (iv) a government office; an educational institution or after-school program; a community center; a publicly or privately operated shelter; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity; (v) a correctional facility, a county jail, a police station, or a fire station; a pharmacy, doctor's office; or any person employed by any such entity, or employed by a contractor of such an entity while performing services for the entity;

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD06667-01-3

and (vi) any other person or entity designated or approved, or in a category designated or approved pursuant to regulations of the commissioner in consultation with other appropriate agencies.

(b) "Opioid antagonist" means a drug approved by the Food and Drug Administration that, when administered, negates or neutralizes in whole or in part the pharmacological effects of an opioid in the body. "Opioid antagonist" shall be limited to naloxone and other medications approved by the department for such purpose.

(c) "Health care practitioner" means a health care practitioner licensed, certified, or authorized to practice under title eight of the education law who is authorized thereby to administer drugs, and who is acting within the scope of his or her practice.

2. Possession and use. (a) Any eligible person or entity shall acquire and possess and may use an opioid antagonist for emergency treatment of a person appearing to experience an opioid-related overdose.

(b) An eligible person or entity shall possess at least two provisions of an opioid antagonist at all times.

(c) An eligible person or entity shall designate one or more individuals who have completed the training required by paragraph (d) of this subdivision to be responsible for the storage, maintenance, control, and general oversight of the opioid antagonist acquired by the eligible person or entity.

(d) No one may use an opioid antagonist on behalf of an eligible person or entity unless he or she has successfully completed a training course in the use of opioid antagonists approved by the commissioner, or is directed in a specific instance to use an opioid antagonist by a health care practitioner.

(e) This section does not prohibit the use of an opioid antagonist (i) by a health care practitioner or (ii) by a person acting pursuant to a lawful patient-specific prescription.

(f) Every eligible person and entity authorized to possess and use an opioid antagonist pursuant to this section shall use, maintain and dispose of such antagonist pursuant to regulations of the department.

(g) Nothing in this section shall require any eligible person or entity to administer an opioid antagonist.

3. Prescriptions. (a) A health care practitioner who is authorized to prescribe drugs may prescribe, dispense or provide an opioid antagonist to or for an eligible person or entity by a non-patient-specific prescription.

(b) A pharmacist may dispense an opioid antagonist pursuant to a nonpatient-specific prescription under this subdivision.

(c) This subdivision does not limit any other authority a health care practitioner or pharmacist has to prescribe, dispense, provide or administer an opioid antagonist.

4. Application of other laws. (a) Use of an opioid antagonist pursuant to this section shall be considered first aid or emergency treatment for the purpose of any statute relating to liability.

(b) Purchase, acquisition, possession or use of an opioid antagonist pursuant to this section shall not constitute the unlawful practice of a profession or other violation under title eight of the education law or article thirty-three of this chapter.

(c) Any person otherwise authorized to sell or provide an opioid antagonist may sell or provide it to a person or entity authorized to possess it pursuant to this section.

§ 2. This act shall take effect on the one hundred twentieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.